LBTSF (Almirall) NonCurrent Deferred Liabilities: $0 Mil (As of Mar. 2026)


LBTSF Almirall SA LBTSF
84 GF Score
Price $15.35
GF Value $16.66
! 4 Warning Signs
View Full Analysis

What is Almirall NonCurrent Deferred Liabilities?

Almirall LBTSF 84 NonCurrent Deferred Liabilities is $0 Mil as of Mar. 2026. GuruFocus rates LBTSF with a GF Score™ of 84/100 and a GF Value™ of $16.66. The stock has 4 warning signs investors should review.

Non-Current Deferred Liabilities represents the non-current portion of obligations, which is a liability that usually would have been paid but is now pas due.

Almirall's non-current deferred liabilities for the quarter that ended in Mar. 2026 was $0 Mil.

Almirall NonCurrent Deferred Liabilities Related Terms

Almirall NonCurrent Deferred Liabilities Historical Data

* Premium members only.

The historical data trend for Almirall's NonCurrent Deferred Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Almirall NonCurrent Deferred Liabilities Chart

Almirall Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
NonCurrent Deferred Liabilities
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

Almirall Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
NonCurrent Deferred Liabilities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00
LBTSF
84GF Score
Almirall SA LBTSF
NonCurrent Deferred Liabilities is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis
What does a NonCurrent Deferred Liabilities of $0 Mil mean?
Almirall (LBTSF) has a NonCurrent Deferred Liabilities of $0 Mil as of Mar. 2026. Non-current deferred liabilities represent the company obligations not paid yet not due within the current period. View historical data on Almirall and its competitors.
Is Almirall's NonCurrent Deferred Liabilities too high?
Almirall's current NonCurrent Deferred Liabilities is $0 Mil. Overall, Almirall has a GF Score™ of 84/100, reflecting its overall financial health beyond just this single metric.
How does Almirall's NonCurrent Deferred Liabilities compare to ZTS and UTHR?
Almirall's NonCurrent Deferred Liabilities of $0 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good NonCurrent Deferred Liabilities for a Drug Manufacturers company?
A good NonCurrent Deferred Liabilities depends on the Drug Manufacturers industry context. However, NonCurrent Deferred Liabilities should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high NonCurrent Deferred Liabilities mean?
A high NonCurrent Deferred Liabilities can signal that a stock is expensive relative to its fundamentals. Non-current deferred liabilities represent the company obligations not paid yet not due within the current period. View historical data on Almirall and its competitors. Almirall's current NonCurrent Deferred Liabilities is $0 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Almirall stock overvalued right now?
Almirall (LBTSF) has a current NonCurrent Deferred Liabilities of $0 Mil. The stock's GF Value™ is $16.66, compared to a current price of $15.35 — trading 7.9% below its estimated fair value. The current NonCurrent Deferred Liabilities is $0 Mil. Almirall's overall GF Score™ is 84/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is NonCurrent Deferred Liabilities calculated?
NonCurrent Deferred Liabilities is calculated from a company's financial statements. For Almirall (LBTSF), the current NonCurrent Deferred Liabilities is $0 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Almirall (LBTSF) Overvalued in 2026?

Based on GuruFocus' analysis, Almirall stock appears to be undervalued. The current stock price of $15.35 is trading 7.9% below its estimated GF Value™ of $16.66.

Key valuation signals for LBTSF:

  • NonCurrent Deferred Liabilities: $0 Mil
  • GF Value™: $16.66 vs. price of $15.35 (7.9% below fair value)
  • GF Score™: 84/100 with 4 warning signs

No single metric tells the full story. See the LBTSF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Almirall Business Description

Other Exchanges 0O9B:UKALM:SpainE2Z:Germany
Address Ronda General Mitre 151, Barcelona, ESP, 08022
Almirall SA is a skin-health focused pharmaceutical company based in Barcelona and the parent company of a group engaged in the purchase, manufacture, storage, marketing, and mediation in the sale of pharmaceutical specialities and products, as well as related raw materials. The Group applies science to provide medical solutions focused on skin health diseases and partners with healthcare professionals, and its activities also include cosmetics; chemical, biotechnological and diagnostic products for human, veterinary, agrochemical and food use; instruments and accessories for the chemical, pharmaceutical and clinical industry; and research on active chemical and pharmaceutical ingredients and products.
84GF Score

Get the complete analysis for LBTSF

NonCurrent Deferred Liabilities is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$15.35
Price
$16.66
GF Value